Abstract
Based on the micelle synergism mechanism, a simple and sensitive flow injection chemiluminescence (FI-CL) method for the assay of lornoxicam was described. The CL signal generated from the reaction of Ce (IV) with lornoxicam in acidic solution was very weak, while the interfusion of sodium dodecyl benzene sulfonate (SDBS) resulted in a highly CL intensity. Under the optimum experimental conditions, the CL intensity was proportional to lornoxicam concentration over the range 1.0 × 10−10–7.3 × 10−8 g/mL with a detection limit of 4.9 × 10−11 g/mL (3σ). The relative standard deviation for 11 replicate measurements of 3.0 × 10−9 g/mL of lornoxicam was 1.9%. The proposed method was successfully applied for the assay of lornoxicam in pharmaceuticals, human serum and urine with excellent recovery. The possible mechanism of CL reaction was also discussed briefly.
Similar content being viewed by others
References
Radhofer-Welte S, Rabasseda X (2000) Lornoxicam, a new potent NSAID with an improved tolerability profile. Drugs Today 36:55–76
Balfour JA, Fitton A, Barradell LB (1996) Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 51:639–657
Olkkola KT, Brunetto AV, Mattila MJ (1994) Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharmacokinet 26:107–120
Vane JR, Botting RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47:S78–S87
Berg J, Christoph T, Widerna M, Bodenteich A (1997) Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac6. J Pharmacol Toxicol Meth 37:179–186. doi:10.1016/s1056-8719(97)00016-6
Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D (1999) The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res 48:369–379. doi:10.1007/s000110050474
Memiş D, Karamanlıoğlu B, Turan A, Koyuncu O, Pamukçu Z (2004) Effects of lornoxicam on the physiology of severe sepsis. Crit Care 8:R474–R482. doi:10.1186/cc2969
Byrav PDS, Medhi B, Prakash A, Patyar S, Wadhwa S (2009) Lornoxicam: a newer NSAID. IJPMR 20:27–31
Skjodt NM, Davies NM (1998) Clinical pharmacokinetics of lornoxicam: a short half-life oxicam. Clin Pharmacokinet 34:421–428
Taha EA, Salama NN, Abdel FLS (2006) Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-Chloro-4-nitrobenz-2-oxa-1, 3-diazole (NBD-Cl). Chem Pharma Bull 54:653–658. doi:10.1248/cpb.54.653
Taha EA, El-Zanfally ES, Salama NN (2003) Ratio derivative spectrophotometric method for the determination of some oxicams in presence of their alkaline degradation products. Sci Pharm 71:303–320
Nemutlu E, Demircan S, Kir S (2005) Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods. Pharmazie 60:421–425
Venumadhav E, Neeha T, Bhargavi P, Nishat A, Swetha A, Rao GD (2010) New spectrophotometric methods for the determination of lornaxicam in pharmaceutical dosage forms. Int J Pharma Bio Sci 1:491–494
Singh B, Saini G, Sharma DNN, Roy SD, Gautam N (2011) Estimation of lornoxicam in tablet dosage form by UV spectrophotometric method. IJPSR 2(1):102–106
Ghoneim MM, Beltagi AM, Radi A (2002) Square-wave adsorptive stripping voltammetric determination of the anti-inflammatory drug lornoxicam. Anal Sci 18(2):183–186. doi:10.2116/analsci.18.183
Ibrahim C, Nisa K, Sule A (2009) Polarographic determination of lornoxicam in pharmaceutical formulations. CBU J Sci 5:11–18
Patel DJ, Patel VP (2010) Simultaneous determination of paracetamol and lornoxicam in tablets by thin layer chromatography combined with densitometry. Int J Chem Tech Res 2:1929–1932
Taha EA, Salama NN, Abdel FLS (2004) Stability-indicating chromatographic methods for the determination of some oxicams. J AOAC Int 87:366–373
Patil KR, Rane VP, Sangshetti JN, Shinde DB (2009) Stability-indicating LC method for analysis of lornoxicam in the dosage form. Chromatographia 69:1001–1005. doi:10.1365/s10337-009-0982-6
Radhofer-Weltea S, Dittrichb P (1998) Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J Chromatogr B 707:151–159. doi:10.1016/s0378-4347(97)00597-5
Shah DA, Patel NJ, Baldania SL, Chhalotiya UK, Bhatt KK (2011) Stability indicating LC-method for estimation of paracetamol and lornoxicam in combined dosage form. Sci Pharm 79:113–122. doi:10.3797/scipharm.1012-03
Attimarad M (2010) Rapid RP HPLC method for quantitative determination of lornoxicam in tablet. J Basic Clin Pharma 1:115–118
Akiko N, Mihoko N, Mitsuhiro W, Kenichiro N (2005) Semi-micro column HPLC of three oxicam non-steroidal anti-inflammatory drugs in human blood. Bunseki Kagaku 54:755–760
Sahoo M, Syal P, Ingale S, Ingale K, Sindhe S, Sali M, Choudhari VP, Kuchekar BS (2011) Development and validation of a RP-HPLC-PDA method for simultaneous determination of lornoxicam and thiocolchicoside in pharmaceutical dosage form and its application for dissolution study. Int J Res Pharm Sci 2:1–7
Suwa T, Urano H, Shinohara Y, Kokatsu J (1993) Simultaneous high performance liquid chromatographic determination of lornoxicam and its 5′-hydroxy metabolite in human plasma using electrochemical detection. J Chromatogr Biomed 617:105–110. doi:10.1016/0378-4347(93)80427-6
Kim YH, Ji HY, Park ES, Chae SW, Lee HS (2007) Liquid chromatography-electrospray lonization tandem mass spectrometric determination of lornoxicam in human plasma. Arch Pharm Res 30:905–910. doi:10.1007/BF02978844
Zeng YL, Chen XY, Zhang YF, Zhong DF (2004) Determination of lornoxicam in human plasma by LC/MS/MS. Pharmaceutica Sinica 39:132–135
Mervartová K, Polášek M, Calatayud JM (2007) Recent applications of flow-injection and sequential-injection analysis techniques to chemiluminescence determination of pharmaceuticals. J Pharmaceut Biomed 45:367–381. doi:10.1016/j.jpba.2007.08.018
Adcock JL, Francis PS, Barnett NW (2007) Acidic potassium permanganate as a chemiluminescence reagent-A review. Anal Chim Acta 601:36–67. doi:10.1016/j.aca.2007.08.027
Bostick DT, Hercules DM (1975) Quantitative determination of blood glucose using enzyme induced chemiluminescence of luminol. Anal Chem 47:447–452. doi:10.1021/ac60353a039
Malavolti NL, Pilosof D, Nieman TA (1985) Determination of cholesterol with a microporous membrane chemiluminescence cell with cholesterol oxidase in solution. Anal Chim Acta 170:199–207. doi:10.1016/s0003-2670(00)81743-2
Zhao F, Bian L (2010) Cerium (IV)-based chemiluminescence of felodipine sensitized by rhodamine 6 G. Instrum Sci Technol 38:366–375. doi:10.1080/10739149.2010.509141
Wolkoff AW, Larose RH (1975) Separation and detection of low concentrations of polythionates by high speed anion exchange liquid chromatography. Anal Chem 47:1003–1008. doi:10.1021/ac60357a009
Kamruzzaman M, Alam AM, Ferdous T, Lee SH, Kim YH, Kim SH (2011) Ultrasensitive study of gatifloxacin based on its enhancing effect on the cerium (IV)-sodium hyposulfite chemiluminescence reaction in a micellar medium. J Fluoresc 21:1539–1545. doi:10.1007/s10895-011-0842-2
Kenner CT, Busch KW (1979) Quantitative analysis. Macmillan, New York
Job P (1928) Formation and stability of inorganic complexes in solution. Ann Chim 9:113–113
Cheng XL, Zhao LX, Lin JM (2006) Chemiluminescence of ClO -3 - SO 2-3 - Rh6G-SDBS system and its application to the determination of sulfite. Chinese J Chem 24:65–71. doi:10.1002/cjoc.200690023
Acknowledgements
The authors gratefully acknowledge the financial support from Shihezi University.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 251 kb)
Rights and permissions
About this article
Cite this article
Zhao, F., Zhao, W. Investigation on the Micelle-Sensitized Ce (IV) - Lornoxicam-Rh B Chemiluminescence System and its Application. J Fluoresc 22, 529–535 (2012). https://doi.org/10.1007/s10895-011-0987-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10895-011-0987-z